1. H.E. Skipper, Dose intensity versus total dose of chemotherapy: an experimental basis, in: V.T. DeVita, S. Hellman, S.A. Rosenberg (Eds.), Important Advances in Oncology. Lippencott, Philadelphia, PA, 1990, pp. 43–64.
2. High dose chemotherapy for high-risk primary breast cancer: an on-site review of the Bezwoda study;Weiss;Lancet,2000
3. Conventional-dose chemotherapy compared with high dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group (see comments);Stadtmauer;N. Engl. J. Med.,2000
4. A large prospective randomized trial of high dose combination alkylating agents (CPB) with autologous cellular support as consolidation for patients with metastatic breast cancer achieving complete remission after intensive doxorubicin-based induction therapy (AFM);Peters;Proc. Am. Soc. Clin. Oncol. (abstr. 149),1996
5. Y. Nieto, R. Champlin, et al. Status of high dose chemotherapy for breast cancer in the new millennium. Biol Blood Marrow Transpl. (2000) in press.